ConductScience.org, home

Paper33713600

Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer.

Tailor D and 14 others. Cell Chem Biol, 2021. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer. Papers, record 33713600. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33713600

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer.
PubMed
Journal
Cell Chem Biol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
2.57
iCite
Revised in PubMed
2026-08-13
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tailor DDhanir
2Resendez AAngel
3Garcia-Marques FJFernando Jose
4Pandrala MMallesh
5Going CCCatherine C
6Bermudez AAbel
7Kumar VVineet
8Rafat MMarjan
9Nambiar DKDhanya K
10Honkala AAlexander
11Le QTQuynh-Thu
12Sledge GWGeorge W
13Graves EEdward
14Pitteri SJSharon J
15Malhotra SVSanjay V

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Ovarian NeoplasmsMajor topic
Y-Box-Binding Protein 1Major topic
Aged
Animals
Apoptosis
Cell Line
Cell Movement
Cell Proliferation
Cell Survival
Drug Screening Assays, Antitumor
Female
Humans
Middle Aged
Molecular Structure
Rats

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA124435NCI NIH HHSUnited StatesP30CA124435PubMedNIH RePORTER
T32 CA121940NCI NIH HHSUnited StatesT32CA121940PubMed and NIHNIH RePORTER

Download CSV of grants

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124767708Ovarian cancer.Lancet2014https://conductscience.org/library/papers/24767708PubMed
229232469Acquired chemotherapy resistance in ovarian cancer.Ann Oncol2017https://conductscience.org/library/papers/29232469PubMed
32873780Taxol: mechanisms of action and resistance.Ann N Y Acad Sci1986https://conductscience.org/library/papers/2873780PubMed
423641145YB-1 is a Transcription/Translation Factor that Orchestrates the Oncogenome by Hardwiring Signal Transduction to Gene Expression.Transl Oncogenomics2007https://conductscience.org/library/papers/23641145PubMed
524100801Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube.Arch Gynecol Obstet2014https://conductscience.org/library/papers/24100801PubMed
69506530Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids.Int J Cancer1998https://conductscience.org/library/papers/9506530PubMed
77859748Evidence for post-transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cells.EMBO J1995https://conductscience.org/library/papers/7859748PubMed
830422115Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13.Elife2018https://conductscience.org/library/papers/30422115PubMed
925957686Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement.Cell2015https://conductscience.org/library/papers/25957686PubMed
1027923830A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers.Cancer Res2017https://conductscience.org/library/papers/27923830PubMed
1130342537Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs.Mol Cancer2018https://conductscience.org/library/papers/30342537PubMed
1212835670Ovarian cancer: strategies for overcoming resistance to chemotherapy.Nat Rev Cancer2003https://conductscience.org/library/papers/12835670PubMed
1326200936Applications of Fluorine in Medicinal Chemistry.J Med Chem2015https://conductscience.org/library/papers/26200936PubMed
1411325824Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.Cancer Res2001https://conductscience.org/library/papers/11325824PubMed
1524335958Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation.Cancer Res2014https://conductscience.org/library/papers/24335958PubMed
1615542787The role of nuclear Y-box binding protein 1 as a global marker in drug resistance.Mol Cancer Ther2004https://conductscience.org/library/papers/15542787PubMed
179704408Gene regulation by Y-box proteins: coupling control of transcription and translation.Trends Cell Biol1998https://conductscience.org/library/papers/9704408PubMed
1827013200Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway.Cancer Res2016https://conductscience.org/library/papers/27013200PubMed
198102521Biochemistry of multidrug resistance mediated by the multidrug transporter.Annu Rev Biochem1993https://conductscience.org/library/papers/8102521PubMed
201701014Poly(A) tail shortening is the translation-dependent step in c-myc mRNA degradation.Mol Cell Biol1990https://conductscience.org/library/papers/1701014PubMed

See all 58 referencesDownload CSV of references

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
42698848YBX1 as an adaptive RNA hub in cancer: linking state-dependent RNA regulation to tumor immunity, metabolic reprogramming, and therapy resistance.Front Immunol2026https://conductscience.org/library/papers/42698848PubMed
42662718Prioritizing Candidate YB‑1 Cold Shock Domain Ligands via 5D-ElectroShape and Boltz Generative Cofolding.ACS Omega2026https://conductscience.org/library/papers/42662718PubMed
42523350Nuclear translocation of phosphorylated YB-1 via small extracellular vesicles contributes to the malignant phenotype of triple negative breast cancer.bioRxiv2026https://conductscience.org/library/papers/42523350PubMed
42314682Quantitative molecular cartography of emergency myelopoiesis reveals conserved modules of hematopoietic activation.Cell Stem Cell2026https://conductscience.org/library/papers/42314682PubMed
42033033Y-box binding protein-1 at the crossroads of DNA damage response and tumor immune evasion.JNCI Cancer Spectr2026https://conductscience.org/library/papers/42033033PubMed
41994112YBX1 Promotes Drug Resistance in Hepatocellular Carcinoma and Serves as a Potential Therapeutic Target.Res Sq2026https://conductscience.org/library/papers/41994112PubMed
41993887In Silico Analysis of Potential Stabilizer Binding Sites at Protein-RNA Interfaces.Comput Struct Biotechnol J2026https://conductscience.org/library/papers/41993887PubMed
41909745Targeting RNA binding proteins with small-molecule inhibitors: Advances, challenges, and therapeutic opportunities.Acta Pharm Sin B2026https://conductscience.org/library/papers/41909745PubMed
41596179Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural Mesothelioma.Antioxidants (Basel)2026https://conductscience.org/library/papers/41596179PubMed
41557215Discovery of a Novel Small-Molecule Modulator for Full-length YB-1 Protein via Integrated Computational and in vitro Biophysical Approaches.Appl Biochem Biotechnol2026https://conductscience.org/library/papers/41557215PubMed
41214061Investigating prognostic features in high-grade serous ovarian cancer through gene regulatory network inference with single-cell transcriptomic profiles.Sci Rep2025https://conductscience.org/library/papers/41214061PubMed
41205595Non-orthosteric inhibition of enolase 1 impedes growth of triple-negative breast cancer.Cell Rep Med2025https://conductscience.org/library/papers/41205595PubMed
41070608Multifaceted functions of Y‑box binding protein 1 in RNA methylated modifications (Review).Mol Med Rep2025https://conductscience.org/library/papers/41070608PubMed
41025501YBX1&YBX3 as novel targets to potentiate immune checkpoint blockade response in gliomas.Neuro Oncol2026https://conductscience.org/library/papers/41025501PubMed
40846998α-Ketoglutarate dictates AMPK protein synthesis for energy sensing in human cancers.Nat Chem Biol2026https://conductscience.org/library/papers/40846998PubMed
40814288The dual role of RNA-binding proteins: promotion of tumorigenesis, drug resistance, and emerging therapeutic targets.Acta Biochim Biophys Sin (Shanghai)2025https://conductscience.org/library/papers/40814288PubMed
40716510Transcription factor YBX1 orchestrates drug resistance and tumor progression in HCC.Drug Discov Today2025https://conductscience.org/library/papers/40716510PubMed
40216969KPNA2 promotes osteosarcoma progression by regulating the alternative splicing of DDX3X mediated by YBX1.Oncogene2025https://conductscience.org/library/papers/40216969PubMed
40044536Ribosome-directed cancer therapies: the tip of the iceberg?Trends Pharmacol Sci2025https://conductscience.org/library/papers/40044536PubMed
39565541Integrative Investigation of Flavonoids Targeting YBX1 Protein-Protein Interaction Network in Breast Cancer: From Computational Analysis to Experimental Validation.Mol Biotechnol2025https://conductscience.org/library/papers/39565541PubMed

See all 40 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
YBX14904PubTator's text mininghttps://conductscience.org/library/genes/4904

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33713600

GET https://conductscience.org/api/papers/v1/33713600/references?page=2